TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
64,349
|
65,115
|
70,396 |
| Financial expenses |
971
|
9
|
201 |
| Earnings before taxes |
-2,458
|
-3,329
|
3,506 |
| EBITDA |
-2,857
|
-3,204
|
3,942 |
| Total assets |
44,708
|
35,153
|
32,648 |
| Current assets |
44,355
|
34,705
|
32,034 |
| Current liabilities |
29,834
|
17,909
|
10,262 |
| Equity capital |
13,101
|
15,039
|
19,377 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
57
|
65
|
57 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
29.3%
|
42.8%
|
59.4% |
| Turnover per employee |
1,129
|
1,002
|
1,235 |
| Profit as a percentage of turnover |
-3.8%
|
-5.1%
|
5.0% |
| Return on assets (ROA) |
-3.3%
|
-9.4%
|
11.4% |
| Current ratio |
148.7%
|
193.8%
|
312.2% |
| Return on equity (ROE) |
-18.8%
|
-22.1%
|
18.1% |
| Change turnover |
-1,102
|
422
|
-438 |
| Change turnover % |
-2%
|
1%
|
-1% |
| Chg. No. of employees |
-8
|
8
|
-5 |
| Chg. No. of employees % |
-12%
|
14%
|
-8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.